Home health and hospice buyers are processing substantially more information during diligence than in prior transaction cycles, particularly in transactions involving multi-location platforms, complex reimbursement profiles, or accelerated growth. AI-assisted review tools now allow buyers and their advisors to analyze large volumes of clinical documentation, billing records, reimbursement data, contracts, and operational reporting far more quickly than traditional manual review processes allowed. Rather than relying primarily on limited sampling, buyers can identify patterns across broader populations of records much earlier in diligence.
Read the full article: Home Health & Hospice M&A in 2026: How AI is Changing Diligence and Deal Execution //
Source: https://www.jdsupra.com/legalnews/home-health-hospice-m-a-in-2026-how-ai-5869375/